title: Validating A Model To Predict Disease Progression Outcomes In Patients With COPD.
authors.affiliation: ICON plc (formerly Oxford Outcomes), Toronto, ON, Canada.
authors.forename: N A
authors.initials: NA
authors.lastname: Risebrough
authors.affiliation: University of Glasgow, Glasgow, UK.
authors.forename: A
authors.initials: A
authors.lastname: Briggs
authors.affiliation: ICON plc (formerly Oxford Outcomes), Morristown, NJ, USA.
authors.forename: T M
authors.initials: TM
authors.lastname: Baker
authors.affiliation: ICON plc, San Francisco, CA, USA.
authors.forename: A
authors.initials: A
authors.lastname: Exuzides
authors.affiliation: ICON plc, San Francisco, CA, USA.
authors.forename: C
authors.initials: C
authors.lastname: Colby
authors.affiliation: Erasmus University Rotterdam, Rotterdam, The Netherlands.
authors.forename: M
authors.initials: M
authors.lastname: Rutten van-Molken
authors.affiliation: GlaxoSmithKline R&D, Uxbridge, UK.
authors.forename: S
authors.initials: S
authors.lastname: Gonzalez McQuire
authors.affiliation: University College London, London, UK.
authors.forename: D
authors.initials: D
authors.lastname: Lomas
authors.affiliation: GlaxoSmithKline R&D, Uxbridge, UK.
authors.forename: H
authors.initials: H
authors.lastname: Muellerova
authors.affiliation: GlaxoSmithKline R&D, King of Prussia, PA, USA.
authors.forename: R
authors.initials: R
authors.lastname: Tal-Singer
authors.affiliation: GlaxoSmithKline, Research Triangle Park, NC, USA.
authors.forename: A
authors.initials: A
authors.lastname: Ismaila